Repligen Corp. (RGEN)
181.69
+0.56
(+0.31%)
USD |
NASDAQ |
Aug 24, 16:00
181.69
0.00 (0.00%)
After-Hours: 20:00
Repligen EPS Diluted (Quarterly) : 0.0884 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0884 |
| March 31, 2026 | 0.147 |
| December 31, 2025 | 0.2345 |
| September 30, 2025 | 0.2638 |
| June 30, 2025 | 0.2631 |
| March 31, 2025 | 0.1031 |
| December 31, 2024 | -0.6042 |
| September 30, 2024 | -0.0117 |
| June 30, 2024 | 0.1012 |
| March 31, 2024 | 0.0583 |
| December 31, 2023 | -0.295 |
| September 30, 2023 | 0.2972 |
| June 30, 2023 | 0.348 |
| March 31, 2023 | 0.2688 |
| December 31, 2022 | 0.8533 |
| September 30, 2022 | 0.7051 |
| June 30, 2022 | 0.8791 |
| March 31, 2022 | 0.7985 |
| December 31, 2021 | 0.5044 |
| September 30, 2021 | 0.5839 |
| June 30, 2021 | 0.6381 |
| March 31, 2021 | 0.5179 |
| December 31, 2020 | 0.358 |
| September 30, 2020 | 0.2722 |
| June 30, 2020 | 0.2976 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1848 |
| December 31, 2019 | 0.068 |
| September 30, 2019 | 0.032 |
| June 30, 2019 | 0.165 |
| March 31, 2019 | 0.174 |
| December 31, 2018 | 0.1218 |
| September 30, 2018 | 0.10 |
| June 30, 2018 | 0.06 |
| March 31, 2018 | 0.08 |
| December 31, 2017 | 0.27 |
| September 30, 2017 | 0.11 |
| June 30, 2017 | 0.24 |
| March 31, 2017 | 0.09 |
| December 31, 2016 | 0.15 |
| September 30, 2016 | 0.03 |
| June 30, 2016 | 0.11 |
| March 31, 2016 | 0.05 |
| December 31, 2015 | 0.01 |
| September 30, 2015 | 0.08 |
| June 30, 2015 | 0.11 |
| March 31, 2015 | 0.09 |
| December 31, 2014 | -0.01 |
| September 30, 2014 | 0.04 |
| June 30, 2014 | 0.09 |
| March 31, 2014 | 0.13 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 0.915 |
| Danaher Corp. | 1.230 |
| Liquidia Corp. | 0.7369 |
| Harmony Biosciences Holdings, Inc. | 1.284 |
| Agilent Technologies, Inc. | 1.198 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.008M |
| Revenue (Quarterly) | 204.13M |
| Total Expenses (Quarterly) | 199.12M |
| Enterprise Value | 10.10B |
| Gross Profit Margin (Quarterly) | 49.25% |
| Profit Margin (Quarterly) | 2.45% |
| Earnings Yield | 0.40% |
| Operating Earnings Yield | 0.69% |
| Normalized Earnings Yield | 0.4492 |